Literature DB >> 28663038

Measuring fatigue with multiple instruments in a Brazilian cohort of early rheumatoid arthritis patients.

Leonardo Rios Diniz1, Sandor Balsamo2, Talita Yokoy de Souza3, Luciana Feitosa Muniz3, Wagner Rodrigues Martins4, Licia Maria Henrique da Mota5.   

Abstract

OBJECTIVE: To assess the prevalence of fatigue in a Brazilian population with early rheumatoid arthritis using multiple instruments, and the predictors of these instruments by differents independent variables.
METHODS: Cross-sectional study with direct interview and medical records review. Fatigue, dependent variable, was assessed using eight instruments: Profile of Mood States (POMS), Multidimensional Assessment of Fatigue scale (MAF), Fatigue Severity Scale (FSS), Bristol Rheumatoid Arthritis Fatigue Multidimensional Questionnaire (BRAF-MDQ), Numerical Rating Scales (BRAF-NRS), Short-form Survey 36 (SF-36), Functional Assessment of Chronic Illness Therapy Fatigue Scale (FACIT-F) and Visual Analogic Scale for Fatigue (VASf). INDEPENDENT VARIABLES: sociodemographic, clinical and serological, were measured using medical records and direct interview. Disability and disease activity were assessed using the Health Assessment Questionnaire (HAQ) and disease activity assessed using the Disease Activity Score 28 joints (DAS28). The scores of scales demonstrated the level of fatigue and multiple linear regression method used in statistical analysis to demonstrate prediction models.
RESULTS: A total of 80 patients was assessed, and 57 reported clinically relevant fatigue (VASf>2), representing 71.25% prevalence point (51 women [89.5%], mean age 48.35±15 years, and mean disease duration of 4.92±3.8 years). Eight predictive models showed statistical significance, one for each fatigue instrument. The highest coefficient of determination (R2) was 56% for SF-36 and the lowest (R2=21%) for FSS. The HAQ was the only independent variable to predict fatigue on all instruments.
CONCLUSION: Clinically relevant fatigue is a highly prevalent symptom and is mostly predicted by disability and age in the population assessed.
Copyright © 2017 Elsevier Editora Ltda. All rights reserved.

Entities:  

Keywords:  Artrite reumatoide; Disability; Fadiga; Fatigue; Incapacidade; Rheumatoid arthritis

Mesh:

Year:  2017        PMID: 28663038     DOI: 10.1016/j.rbre.2017.05.004

Source DB:  PubMed          Journal:  Rev Bras Reumatol Engl Ed        ISSN: 2255-5021


  6 in total

1.  The relationship between bristol rheumatoid arthritis fatigue scales and disease activity of patients with rheumatoid arthritis.

Authors:  Seda Colak; Sevinc Can Sandikci; Derya Gokmen; Ahmet Omma
Journal:  Clin Rheumatol       Date:  2018-07-30       Impact factor: 2.980

2.  Assessing Religious Commitment in a Multicultural Inpatient Setting: A Psychometric Evaluation of the 10-item Belief into Action Scale.

Authors:  Laura S Castro; Tracy A Balboni; Talita C Lobo; Rita Simone L Moreira; Harold G Koenig; John R Peteet; Fatima Cintra
Journal:  J Relig Health       Date:  2021-03-12

3.  Patient-reported fatigue in patients with rheumatoid arthritis who commence biologic therapy: a longitudinal study.

Authors:  Hege Selheim Rinke; Clara Beate Gram Gjesdal; Heidi Markussen; Jörg Assmus; Gerd Karin Natvig
Journal:  PeerJ       Date:  2019-04-17       Impact factor: 2.984

4.  Severity of fatigue in people with rheumatoid arthritis, psoriatic arthritis and spondyloarthritis - Results of a cross-sectional study.

Authors:  Trine Pilgaard; Lise Hagelund; Sandra Elkjær Stallknecht; Henrik Holm Jensen; Bente Appel Esbensen
Journal:  PLoS One       Date:  2019-06-28       Impact factor: 3.240

5.  A biopsychosocial network model of fatigue in rheumatoid arthritis: a systematic review.

Authors:  Rinie Geenen; Emma Dures
Journal:  Rheumatology (Oxford)       Date:  2019-11-01       Impact factor: 7.580

6.  Fatigue assessment by FACIT-F scale in Pakistani cohort with Rheumatoid Arthritis (FAF-RA) study.

Authors:  Abrar Ahmed Wagan; Abdul Raheem; Afra Bhatti; Taimoor Zafar
Journal:  Pak J Med Sci       Date:  2021 Jul-Aug       Impact factor: 1.088

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.